for melioidosis [2] , aminoglycosides for plague and tularemia, and fluoroquinolones as 6 alternatives for the latter two diseases [1] . All three pathogens are facultative intracellular 7 organisms, thriving in the cytosol [3] , the phagolysosomes [4] or in both [5] . Validated in-vitro 8 pharmacodynamic models [6] have demonstrated that β-lactams and aminoglycosides fail to 9 eradicate intracellular bacteria, irrespective of their subcellular localization [6] [7] [8] . 10
Fluoroquinolones display better intracellular efficacy [7] [8] [9] [10] but have not been evaluated in 11 pharmacodynamic models against these biothreat agents. Here, we compare three 12 fluoroquinolones (finafloxacin, ciprofloxacin, and levofloxacin) with imipenem for activity in 13 human THP-1 monocytes [10] infected by Burkholderia thailandensis, 14
Yersinia pseudotuberculosis, and Francisella philomiragia, which are appropriate surrogates 15 for the corresponding biothreat agents with regards to their intracellular fate [11] [12] [13] . 16 Finafloxacin has been shown to have enhanced activity at mild acidic pH [14;15] , which could 17 confer an advantage when considering bacteria sojourning in phagolysosomes and other 18 acidic microenvironments [16] . We also studied the cellular pharmacokinetics of finafloxacin. 19
Materials and Methods

21
Antibiotics 22
Levofloxacin and imipenem were procured as TAVANIC® and TIENAM®, respectively. 23 Finafloxacin HCl (potency, 84.19%) was from MerLion Pharmaceuticals GmbH (Berlin,  24 Germany), ciprofloxacin (potency, 98%) from Sigma-Aldrich (St-Louis, MO), and gentamicin 25 sulfate (potency, 60.7%) from VWR, Radnor, PA. [ 
MIC determination 38
MICs were determined by broth microdilution in CA-MHB at pH 7.4 or adjusted to pH 6.5 or 39
by addition of HCl. 40 41
Extracellular antibiotic activity 42
Concentration-kill curves were determined after 24h of incubation in CA-MHB adjusted to pH 43 7.4 or 5.5 using a starting inoculum of 10 6 cfu/mL (see Figure S1 ) and antibiotic 44 concentrations ranging from 0.003 to 100xMIC. Serially diluted aliquots were plated on agar 45 containing 0.4% activated charcoal to adsorb residual antibiotic. 46
47
Intracellular models of infection 48
We adapted the protocol developed for P. aeruginosa and THP-1 monocytes [10] (see 49 Figure S2 for details and model validation). Bacteria (opsonized with human serum) were 50 added to monocytes to obtain suitable bacteria:cell ratios, and incubated at 37°C in 5% CO2 51 to allow for phagocytosis. Cells were pelleted by centrifugation, washed, and incubated for 52 1h with gentamicin at high concentration to kill non-internalized bacteria. Cells were re-53 pelleted, washed, and resuspended in culture medium. The integrity of the pericellular 54 membrane of THP-1 cells was evaluated (trypan blue), and the remaining sample pelleted, 55 resuspended in water (to lyse cells) and used for protein assay [17] and cfu counting (by 56 plating onto charcoal-supplemented media). 57
58
Intracellular antibiotic activity 59
Infected cells were incubated for 24h with antibiotics over a range of concentrations (0.003 to 60 100xMIC) in media adjusted to pH 7.4 or 5.5, following which the cells were collected and 61 their integrity, protein content and cfu counts measured as described above. 62
63
Finafloxacin pharmacokinetics in THP-1 cells 64
We used a published protocol [18] with media buffered at pHs ranging from 5.5 to 7.4 and 65 [ 14 C]-labelled finafloxacin (mixed with unlabeled drug to achieve the desired total 66 concentration). For influx studies, cells were incubated with finafloxacin at 37°C, pelleted by 67 centrifugation, washed in cold PBS, pelleted again (at 4°C) and resuspended in distilled 68 water. They were sonicated and used for radioactivity determination (by scintillation counting) 69 and protein assay. For efflux studies, cells were first incubated with finafloxacin for 2h, 70 pelleted by centrifugation, washed in ice-cold PBS, pelleted again at 4°C, resuspended and 71 then incubated at 37°C in drug-free media (adjusted to the same pH as when studying 72 influx). They were finally collected and used as for the accumulation studies. Drug 73 accumulation (apparent cellular to extracellular concentration ratio) was calculated using a 74 conversion factor of 5 µL of cell volume per mg of cell protein [7] . 
Results
104
Antimicrobial susceptibility 105 Table S1 shows MICs at pHs ranging from 7.4 to 5.5. The values for finafloxacin decreased 106 upon media acidification while those of the other drugs increased. 107
108
Antibiotic activity against extracellular bacteria 109 Figure 1 shows the concentration-effect relationships for antibiotics against the 3 bacteria in 110
CA-MHB at pH 7.4 or pH 5.5, with the corresponding pharmacodynamic parameters shown 111 in Table 1 . All antibiotics were highly bactericidal, with cfu counts below the limit of detection 112 at low multiples (2-6-fold) of their MIC. At pH 5.5, the concentration-response curve for 113 finafloxacin was shifted to the left (lower Cs, denoting a greater potency) but to the right 114 (higher Cs, denoting a lower potency) for the other antibiotics (see Figure S3 Here also, this could be ascribed to its higher proportion of zwitterionic species. At neutral 188 pH, efflux proceeded at a rate similar to that of influx, suggesting diffusion as the only 189 process involved (as for moxifloxacin [26] ). In contrast, finafloxacin efflux was much slower 190 than influx at pH 5. accumulation levels against other intracellular bacteria, and has been ascribed to 215 commensurate differences in intracellular bioavailability [28] . Conversely, finafloxacin 216 demonstrated both an increased relative potency (lower Cs) and a higher cellular 217 accumulation when experiments were conducted at acidic pH rather than at a neutral pH, 218 linking activity to accumulation levels in these conditions. 219 220 Lastly, finafloxacin, as other fluoroquinolones [21;28] , showed similar intracellular activity 221 against bacterial species localized in different subcellular compartments, although being 222 predominantly recovered in the cell supernate in both uninfected and infected cells. Similar 223 observations have been made earlier for other antibiotics from different pharmacological 224 classes but which, like finafloxacin, show a rapid influx and efflux from THP-1 cells [18;19] , 225 suggesting that they all easily diffuse through membranes. Since fluoroquinolones are not 226 irreversibly bound to their bacterial target, we are probably witnessing a dissociation of 227 finafloxacin from its site of action due to the extensive dilution of the samples taking place 228 during the cell homogenization and fractionation procedures. This would also imply that 229 finafloxacin can easily move across both intracellular and bacterial membranes, explaining 230 why it may exert antibacterial activity against bacteria located in different subcellular 231 compartments. This is in contrast to less diffusible drugs such as oritavancin, which enters 232 eukaryotic cells by endocytosis but is thereafter restricted to phagolysosomes, acting easily 233 upon S. aureus located within these organelles but not against cytosolic L. monocytogenes 234 [22] . 235
236
There are two recognized limitations from this work. Firstly, for evident safety reasons, we 237 used surrogates of the biothreat pathogens, and could therefore not take into account a 238 possible influence of specific virulence factors in the response from these human pathogens 239 to antibiotics. Secondly, we used a single phagocytic cell type, which does not necessarily 240 represent the repertoire of cells infected in vivo by these bacteria, but it was selected as a 241 permissive cell line allowing to assess the antibiotic effect without interference of cell defense 242
mechanisms. Yet, taken globally, our data provide strong support for the further evaluation 243 of finafloxacin against the intracellular forms of these biothreat pathogens. Table 2 Figure S1 for Data description : The aim when developing these intracellular models is to obtain a sufficiently large intracellular inoculum (approx. 10 6 cfu/mg cell protein) for use in these assays whilst minimizing cytotoxicity related to bacterial virulence. As shown in the figure low inocula yielded sufficient internalization for B. thailandensis and Y. pseudotuberculosis, but much larger ones (also conferring more cytotoxicity) were required for F. philomiragia (which is known to be poorly internalized [4] [5] [6] Table 1 for these values). The Y axis in the graphs shows the ratio between the Cs value at neutral pH and at acidic pH for each bacterium and each antibiotic), expressed in log scale. A positive value therefore corresponds to a decrease in Cs upon acidification of the medium (higher relative potency) and a negative value, to an increase in Cs upon acidification of the medium (lower relative potency). ND: not determined because a static effect was not reached against F. philomiragia intracellularly. Table S2 for actual values).
Ionization status: As the pKa of the carboxylic function of finafloxacin is lower than for the other fluoroquinolones (4.33 vs. 5.56 and 5.35 for ciprofloxacin and levofloxacin, respectively (see Table S2 ), the molecule is expected to be essentially zwitterionic at acid pH (92% at pH 5.5) whereas the two other fluoroquinolones are largely positively-charged. We suggest that the nitrile substituent present in position 8 plays a critical role in this respect since (i) calculations show that descyanofinafloxacin loses this predominantly zwitterionic character at acid pH (and becomes as positively-charged as ciprofloxacin), and (ii) pradofloxacin, another fluoroquinolone carrying a nitrile group in C8, has lower MICs at an acid pH than its C8-H analogue (descyanopradofloxacin) [7] . Experimental determinations of the actual proportions of finafloxacin and ciprofloxacin microspecies at neutral and acidic pH would be worthwhile to be obtained for confirmation of this hypothesis.
